Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen's Fampyra Launched in Canada
Yahoo/Zacks
Saturday, April 14, 2012 - 12:39pm
tags:
Biogen Idec, Fampyra, multiple sclerosis
Ample Supplies of Shingles Vaccine Return
WSJ
Saturday, April 14, 2012 - 12:38pm
tags:
shingles, Merck, Zostavax
Are Merck’s Top Investors Waiting for Catalysts to Bid Shares Higher in 2012?
Wall St. Cheat Sheet
Saturday, April 14, 2012 - 12:37pm
tags:
Merck
Pfizer, OSI Sue Roxane Over Generic Tarceva Cancer Drug
Bloomberg
Saturday, April 14, 2012 - 12:36pm
tags:
Pfizer, OSI Pharmaceuticals
J&J’s Gorsky Should Be Forced to Testify in Suit, U.S. Says
Bloomberg
Saturday, April 14, 2012 - 12:33pm
tags:
JNJ, Alex Gorsky, legal, lawsuit
Abbott Laboratories First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Saturday, April 14, 2012 - 12:31pm
tags:
Abbott Laboratories, earnings
It's Fashionably Late, but This Biotech's Party Is Just Starting
Motley Fool
Saturday, April 14, 2012 - 12:27pm
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma
Vivus Could Surge On Qnexa Approval
Motley Fool
Saturday, April 14, 2012 - 12:25pm
tags:
Vivus, Qnexa, obesity
Questcor Could Shoot Higher On Acthar's Versatility
Motley Fool
Saturday, April 14, 2012 - 12:23pm
tags:
Questcor, Acthar, multiple sclerosis, nephrotic syndrome, infantile spasms
Optimer Pharma Evenly Poised
Yahoo/Zacks
Saturday, April 14, 2012 - 12:22pm
tags:
Optimer Pharmaceuticals
2 Attractive Biotech Stocks, With Good Entry Points
Seeking Alpha
Saturday, April 14, 2012 - 12:21pm
tags:
Horizon Pharma, Duexis, Lodotra, arthritis, rheumatoid arthritis, pain management
HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail
Seeking Alpha
Saturday, April 14, 2012 - 12:19pm
tags:
Human Genome Sciences, albiglutide, darapladib, Emergent BioSolutions, diabetes, Biogen Idec, lupus
Spectrum Pharmaceuticals: A Strong Growth Stock In 2012
Motley Fool
Saturday, April 14, 2012 - 12:16pm
tags:
Spectrum Pharmaceuticals
Spectrum Will Sink Until 2013
Seeking Alpha
Saturday, April 14, 2012 - 12:11pm
tags:
Spectrum Pharmaceuticals
Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Fierce Biotech
Friday, April 13, 2012 - 10:51am
tags:
Tioga, venture capital, D-IBS, irritable bowel syndrome, Series B, asimadoline
Affymax gets Medicare payment code for Omontys
Yahoo/AP
Friday, April 13, 2012 - 10:47am
tags:
Affymax, Omontys, Medicare, anemia
Earnings Preview: Forest Laboratories
Forbes
Friday, April 13, 2012 - 10:02am
tags:
earnings, Forest Labs
Drugmakers Refuse To Back Down Over ALEC
Pharmalot
Friday, April 13, 2012 - 10:00am
tags:
ALEC, American Legislative Exchange Council
Shire scoops up Pervasis Therapeutics
Mass High Tech
Friday, April 13, 2012 - 9:59am
tags:
Pervasis Therapeutics, Shire, M&A, regenerative medicine
Novartis MS Patient Develops Rare Brain Disease
Pharmalot
Friday, April 13, 2012 - 9:57am
tags:
Gilenya, MS, multiple sclerosis, PML, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.